Related Experiment Video

Updated: Oct 29, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.2K

Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction-Prevalence, Importance and

Mohamed Farag1,2, Marta Peverelli3, Nikolaos Spinthakis4

  • 1Cardiothoracic Department, Freeman Hospital, Newcastle Upon Tyne, UK. mohamedfarag@nhs.net.

Cardiovascular Drugs and Therapy
|July 10, 2021
PubMed

Insights

Patients with transient ST-elevation myocardial infarction (STEMI) experiencing spontaneous resolution (SpR) may benefit from delayed angiography. Deferring intervention for 24-48 hours appears safe and potentially improves outcomes compared to immediate procedures.

Area of Science:

  • Cardiology
  • Clinical Medicine

Background:

  • Transient ST-elevation myocardial infarction (STEMI) with spontaneous resolution (SpR) presents a unique management challenge.
  • Optimal therapeutic strategies for this patient cohort remain debated, particularly regarding the timing of percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To review potential mechanisms of SpR in STEMI.
  • To examine the relationship between SpR and clinical outcomes.
  • To discuss management options for transient STEMI, focusing on immediate vs. early PCI.

Main Methods:

  • A structured literature search was conducted using PubMed and Cochrane Library databases.
  • Studies published from inception to December 2020 focusing on SpR in acute coronary syndrome were selected for review.

Main Results:

  • Available data suggest that deferring angiography and revascularization for 24-48 hours in patients with transient STEMI is a reasonable approach.
  • This delayed strategy appears associated with similar or potentially better clinical outcomes compared to immediate angiography.

Conclusions:

  • Deferral of angiography and revascularization may be a safe and effective strategy for patients with transient STEMI and SpR.
  • Further randomized trials are necessary to definitively establish optimal pharmacological and invasive management strategies for this specific patient group.

Keywords:
Myocardial infarctionOutcomePercutaneous coronary interventionSpontaneous resolution

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.4K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
191
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
41
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
155
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
55